Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
A Review of the Advanced Immunogens for the Protection of Poultry Flocks Against Infectious Laryngotracheitis Virus
Author(s):
1. Ahmed I. Alajaji: Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Qassim University, Buraydah, 51452, Saudi Arabia
Abstract:
Infectious laryngotracheitis virus is a member of a family of herpes viruses causing infection in avian species. It is a deadly virus that causes infection in multiple species of avians causing respiratory and ocular infections. ILT virus causes high mortalities, morbidities and economic losses in commercial poultry flocks. Traditionally, ILT is managed by the vaccination through live attenuated viruses synthesized either through tissue culturing or passaging through chicken embryos. The viral vector vaccines are also now commonly used commercially. Recent research highlights novel immunogenic candidates, which include viral vectors, genome-attenuated viruses, subunit vaccines, and DNA particles. The results of these vaccines have been tested in in vivo environment and they are providing sufficient levels of immunity against ILT. Further research is needed to remove the constraints of these vaccines to be used commercially.
Page(s): 1006-1012
Published: Journal: Pakistan Veterinary Journal, Volume: 44, Issue: 4, Year: 2024
Keywords:
Chicken Immunity Infectious laryngotracheitis Virus vaccine Live attenuated
References:
[1] Abdelaziz K,Helmy YA,Yitbarek A .2024 .Advances in poultry vaccines: Leveraging biotechnology for improving vaccine development, stability, and delivery. Vaccines, 12(2) : 134.
[2] Abushattal S,Vences A,Osorio CR .2022 .A highly unstable and elusive plasmid that encodes the type III secretion system is necessary for full virulence in the marine fish pathogen Photobacterium damselae subsp. piscicida. Int J Mol Sci, 23(9) : 4729.
[3] Ahaduzzaman M,Groves PJ,Sharpe SM .2020 .A practical method for assessing infectious laryngotracheitis vaccine take in broilers following mass administration in water: Spatial and temporal variation in viral genome content of poultry dust after vaccination. Vet Microbiol, 241 : 108545.
[4] Assen AM,Gerber PF,Walkden-Brown SW .2023 .Protection efficacy of the infectious laryngotracheitis (ILT) serva ceo vaccine strain in broiler chickens under different vaccination coverage conditions. Avian Dis, 67(2) : 160-169.
[5] Assen AM,Stillman M,Alfirevich S .2020 .Assessment of A20 infectious laryngotracheitis vaccine take in meat chickens using swab and dust samples following mass vaccination in drinking water. Vet Microbiol, 251 : 108903.
[6] Atasoy MO,Rohaim MA,Munir M .2019 .Simultaneous deletion of virulence factors and insertion of antigens into the infectious laryngotracheitis virus using NHEJ-CRISPR/Cas9 and cre-lox system for construction of a stable vaccine vector. Vaccines, 7(4) : 207.
[7] Bagust TJ,Johnson MA .1995 .Avian infectious laryngotracheitis:Virushost interactions in relation to prospects for eradication. Avian Pathol, 24(3) : 373-391.
[8] Barbosa LN,Lianes A,Madesh S .2024 .Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge. PLOS Neglected Trop Diseas, 18(9) : e0012155.
[9] Barboza-Solis C,Contreras AP,Palomino-Tapia VA .2020 .Genotyping of Infectious Laryngotracheitis Virus (ILTV) isolates from western canadian provinces of Alberta and British Columbia Based on partial open reading frame (ORF) a and b. Animals, 10(9) : 1634.
[10] Barboza-Solis C,Najimudeen SM,Perez-Contreras A .2021 .Evaluation of recombinant herpesvirus of turkey laryngotracheitis (rHVT-LT) vaccine against genotype VI Canadian wild-type infectious laryngotracheitis virus (ILTV) infection. Vaccines, 9(12) : 1425.
[11] Bayoumi M,El-Saied M,Amer H .2020 .Molecular characterization and genetic diversity of the infectious laryngotracheitis virus strains circulating in Egypt during the outbreaks of 2018 and 2019. Arch Virol, 165 : 661-670.
[12] Becerra R,Maekawa D,García M .2023 .Protection efficacy of recombinant HVT-ND-LT and the live attenuated tissue culture origin vaccines against infectious laryngotracheitis virus when administered individually or in combination. Avian Dis, 67(2) : 145-152.
[13] Bela-Ong DB,Thompson KD,Kim HJ .2023 .T lymphocyte responses to viruses and virus-relevant stimuli in teleost fish. Fish Shellfish Immunol, 142 : 109007.
[14] Bhujbal S,Bhujbal R,Giram P .2022 .An overview: CRISPR/Cas-based gene editing for viral vaccine development. Exp Rev Vaccin, 21(11) : 1581-1593.
[15] Bindari YR,Walkden-Brown SW,Gerber PF .2020 .Methods to prevent PCR amplification of DNA from non-viable virus were not successful for infectious laryngotracheitis virus. PLoS One, 15(5) : e0232571.
[16] Bublot M .2024 .Poultry vaccine technology platforms. Avian Dis, 67(4) : 380-401.
[17] Chen H-Y H-Y .2011 .Interleukin-18-mediated enhancement of the protective effect of an infectious laryngotracheitis virus glycoprotein B plasmid DNA vaccine in chickens. J Med Microbiol, 60(1) : 110-116.
[18] Chen J,Fang M,Li Y .2024 .Cell surface protein-protein interaction profiling for biological network analysis and novel target discovery. Life Med, 3(4) : lnae031.
[19] Chen S,Xu N,Ta L .2020 .Recombinant fowlpox virus expressing gB gene from predominantly epidemic infectious larygnotracheitis virus strain demonstrates better immune protection in SPF chickens. Vaccine, 8(4) : 623.
[20] Cheng J,Lei H,Xie C .2023 .B lymphocyte development in the bursa of fabricius of young broilers is influenced by the gut microbiota. Microbiol Spect, 11(2) : e04799-04722.
[21] Choy RKM,Bourgeois AL,Ockenhouse CF .2022 .Controlled human infection models to accelerate vaccine development. Clin Microbiol Rev, 35(3) : e00008-00021.
[22] Cid R and Bolívar J .2021 .Platforms for production of protein-based vaccines: from classical to next-generation strategies. Biomolecul, 11(8) : 1072.
[23] Citarasu T,Uma G,Kumar RS .2023 .Biotechnological approaches to vaccines. , : 127-153.
[24] Conrady CD,Yeh S .2021 .A review of ocular drug delivery platforms and drugs for infectious and noninfectious uveitis: the past, present, and future. Pharmaceutics, 13(8) : 1224.
[25] Coppo MJC,Noormohammadi AH,Browning GF .2013 .Challenges and recent advancements in infectious laryngotracheitis virus vaccines. Avian Pathol, 42(3) : 195-205.
[26] Dong X,Deng P,Wang X .2024 .Structural characteristics and immunomodulatory effects of polysaccharides extracted from plant seeds:A review. Trend Food Sci Tech, 153 : 104747.
[27] El-Saied M,El-Mahdy MM,Bayoumi M .2022 .Pathogenicity and vaccine efficacy of two virulent infectious laryngotracheitis virus strains in Egypt. BMC Vet Res, 18(1) : 358.
[28] El Boraey D,Ayoub MA,Shaaban SI .2024 .Freezing, heating and some factors affecting immune response induced by inactivated vaccines in broiler chickens. J Curren Vet Res, 6(1) : 253-271.
[29] Elshafiee EA,Hassan MSH,Provost C .2022 .Comparative full genome sequence analysis of wild-type and chicken embryo origin vaccinelike infectious laryngotracheitis virus field isolates from Canada. Infect, Genetic Evolution, 104 : 105350.
[30] Fakhri O,Devlin JM,Browning GF .2020 .Superinfection and recombination of infectious laryngotracheitis virus vaccines in the natural host. Vaccine, 38(47) : 7508-7516.
[31] Gaghan C,Browning M,Cortes AL .2023 .Effect of CpGOligonucleotide in enhancing recombinant herpes virus of turkeylaryngotracheitis vaccine-induced immune responses in one-day-old broiler chickens. Vaccine, 11 : 294.
[32] Gamal MA,Soliman Y .2023 .Humoral and Interferon-γ Immune response to DNA vaccine encoding the surface glycoprotein b of infectious laryngotracheitis virus. Egyptian J Vet Res, 54(4) : 631-642.
[33] Ganapathy K and Parthiban S .2024 .Pros and cons on use of live viral vaccines in commercial chicken flocks. Avian Dis, 67(4) : 410-420.
[34] Gao XH,Tang JJ,Liu HR .2019 .Structure-activity study of fluorine or chlorine‐substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Develop Res, 80(4) : 438-445.
[35] García M .2017 .Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry. Vet Microbiol, 206 : 157-162.
[36] García M and Zavala G .2019 .Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain. Avian Dis, 63(2) : 325-334.
[37] Gopakumar G,Diaz-Méndez A,Coppo MJC .2024 .Transcriptomic analyses of host-virus interactions during in vitro infection with wild-type and glycoprotein g-deficient (ΔgG) strains of ILTV in primary and continuous cell cultures. Plos One, 19(10) : e0311874.
[38] Gowen BB,Hickerson BT,York J .2021 .Second-generation liveattenuated Candid# 1 vaccine virus resists reversion and protects against lethal Junín virus infection in guinea pigs. J Virol, 95(14) : 10-1128.
[39] Gowthaman V,Kumar S,Koul M .2020 .Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control-a comprehensive review. Vet Quarter, 40(1) : 140-161.
[40] Gul H,Habib G,Khan IM .2022 .Genetic resilience in chickens against bacterial, viral and protozoal pathogens. Front Vet Sci, 9 : 1032983.
[41] Gupta S and Pellett S .2023 .Recent developments in vaccine design: from live vaccines to recombinant toxin vaccines. Toxin, 15(9) : 563.
[42] Guyonnet V,Peters AR .2020 .Are current avian influenza vaccines a solution for smallholder poultry farmers?. Gates Open Res, 4 : 122.
[43] Hassan MSH,Abdul-Careem MF .2020 .Avian viruses that impact table egg production. Animals, 10(10) : 1747.
[44] Hellmich R,Sid H,Lengyel K .2020 .Acquiring resistance against a retroviral infection via CRISPR/Cas9 targeted genome editing in a commercial chicken line. Front Genome Edit, 2 : 3.
[45] Hira P .2022 .Overview of immune system, an interplay of cellular and molecular components of immunology. , 1 : 1-26.
[46] Imhof D,Hänggeli KPA,De Sousa MCF KPA .2024 .Working towards the development of vaccines and chemotherapeutics against neosporosis-With all of its ups and downs-Looking ahead. Adv Parasitol, 124 : 91-154.
[47] Jiang L,Cheng J,Pan H .2024 .Analysis of the recombination and evolution of the new type mutant pseudorabies virus XJ5 in China. BMC Genom, 25(1) : 752.
[48] Jogi HR,Smaraki N,Rajak KK .2024 .Revolutionizing Veterinary Health with Viral Vector-Based Vaccines. , 1 : 12.
[49] Kangethe RT,Winger EM,Settypalli TBK .2022 .Low dose gamma irradiation of trypanosoma evansi parasites identifies molecular changes that occur to repair radiation damage and gene transcripts that may be involved in establishing disease in mice post-irradiation. Front Immunol, 13 : 852091.
[50] Kim Y-M,Woo S-J and Han J-Y .2023 .Strategies for the generation of gene modified avian models: advancement in avian germline transmission, genome editing, and applications. Gene, 14(4) : 899.
[51] Li H,Zhang C,Fan R .2016 .The effects of Chuanxiong on the pharmacokinetics of warfarin in rats after biliary drainage. J Ethnopharm, 193 : 117-124.
[52] Lin X,Liao Y,Chen X .2016 .Regulation of oncoprotein 18/Stathmin signaling by ERK concerns the resistance to taxol in nonsmall cell lung cancer cells. Can Bioth Radiopharma, 31(2) : 37-43.
[53] Liu T,Lin L,Pan Y .2024 .Construction and Efficacy of recombinant Newcastle disease virus co-expressing VP2 and VP3 proteins of very virulent infectious bursal disease virus. Poul Sci, 104(1) : 104388.
[54] Lopez SMC,Sato AI,Chatterjee A .2023 .Vaccines: an overview. Viral Parasit Bacter Fungal Infect, : 699-717.
[55] Maricarmen G and Guillermo Z .2019 .Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain. Avian Dis, 63(2) : 325-334.
[56] Matić Z and Šantak M .2022 .Current view on novel vaccine technologies to combat human infectious diseases. App Microbiol Immunol, 106 : 25-56.
[57] Mebatsion T .2021 .Introduction to veterinary vaccines. viral vectors in veterinary vaccine development:. A Textbook, : 3-12.
[58] Meganck RM,Baric RS .2021 .Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nature Med, 27(3) : 401-410.
[59] Munuswamy P,Mariappan AK,Dhama K .2019 .Avian infectious laryngotracheitis. Recent Adv Anim Virol :, : 71-97.
[60] Mustafa S,Abbas RZ,Saeed Z .2024 .Use of metallic nanoparticles against Eimeria-the Coccidiosis-Causing Agents:A Comprehensive Review. Biol Trace Elem Rese, : 1-20.
[61] Nooraei S,Sarkar Lotfabadi A,Akbarzadehmoallemkolaei M .2023 .Immunogenicity of different types of adjuvants and nano-adjuvants in veterinary vaccines: a comprehensive review. Vaccine, 11(2) : 453.
[62] Nunberg JH,Westover JB,York J .2024 .Restoration of virulence in the attenuated Candid# 1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC. J Virol, 98(4) : e00112-00124.
[63] Pajić M,Knežević S,Djurdjević B .2022 .Diagnosis of infectious laryngotracheitis outbreaks on layer hen and broiler breeder farms in Vojvodina, Serbia. Animals, 12(24) : 3551.
[64] Palomino-Tapia VA,Zavala G,Cheng S .2023 .Attenuation of a field strain of infectious laryngotracheitis virus in primary chicken culture cells and adaptation to secondary chicken embryo fibroblasts. Poultry, 2(4) : 516-530.
[65] Pankrac JP .2020 .Development and evaluation of a heterogenous viruslike particle (VLP) formulation to achieve HIV-1 latency reversal and cure. ProQuest Dissertations & Theses 29247273., : .
[66] Perez-Contreras A,Barboza-Solis C,Najimudeen SM .2021 .Pathogenic and transmission potential of wildtype and chicken embryo origin (CEO) vaccine revertant infectious laryngotracheitis virus. Virus, 13(4) : 541.
[67] Perkus ME,Paoletti E .2012 .3.6 Recombinant virus as vaccination carrier of heterologous antigens. Concept Vaccin Develop, : 379.
[68] Qin F,Xia F,Chen H .2021 .A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applicationfront. Cell Immune Biol, 9 : 633776.
[69] Raji AA,Dastjerdi PZ,Omar AR .2024 .Virus-like particles in poultry disease: an approach to effective and safe vaccination. Front Vet, Sci11 : 1405605.
[70] Ravikumar R,Chan J,Prabakaran M .2022 .Vaccines against major poultry viral diseases: strategies to improve the breadth and protective efficacy. Virus, 14(6) : 1195.
[71] Ruan Y,Yuan P-P P-Y .2023 .Tingli Dazao Xiefei Decoction ameliorates asthma in vivo and in vitro from lung to intestine by modifying NO-CO metabolic disorder mediated inflammation, immune imbalance, cellular barrier damage, oxidative stress and intestinal bacterial disorders. J Ethnopharmacol, 313 : 116503.
[72] Sabir AJ,Olaogun OM,O'Rourke D .2020 .Full genomic characterisation of an emerging infectious laryngotracheitis virus class 7b from Australia linked to a vaccine strain revealed its identity. Infect Genet Evol, 78 : 104067.
[73] Saeed Z,Abbas RZ,Khan MK .2023 .Anticoccidial activities of essential oil of Amomum subulatum in broiler chicks. Pak J Agricul Sci, 60(2) : 377-384.
[74] Alkheraije Saeed Z,KA Saeed Z .2023 .Botanicals: A promising approach for controlling cecal coccidiosis in poultry. Front Vet Sci, 10 : 1157633.
[75] Schat KA,Skinner MA .2022 .Avian immunosuppressive diseases and immune evasion. Avian Immunol Elsevier, : 387-417.
[76] Shuja A,Qureshi JA,Shuja N .2022 .Traditional and recent approaches for the development of animal vaccines. Pak J Med Health Sci, 16(12) : 460-460.
[77] Tamilmaran P,Kumar R,Lakkawar AW .2020 .Occurrence and pathology of infectious laryngotracheitis (ILT) in commercial layer chicken. J. Entomol. Zool. Stud, 8 : 1575-1579.
[78] Tariq M,Badshah F,Akbar HMF,Alvi MA,Rashid M,Zafar MA,Mughal MAS .2024 .The Future of Veterinary Vaccines. Complementary and Alternative Medicine: Immunization/Vaccinology, : 110-119.
[79] Triggle CR,Bansal D,Ding H .2021 .A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol, 12 : 631139.
[80] Trovato M,Sartorius R,D'Apice L R .2020 .Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol, 11 : 2130.
[81] Zhang Wang L,H Wang L .2023 .Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina. Drug Deliv Translat Res, 13(2) : 547-567.
[82] Wang Y,Jiang H,Li M .2024 .Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy. Gene, : 148733.
[83] Weiner C .2020 .Relations of science, government and industry:The case of recombinant DNA, Science, Technology, and the Issues of the Eighties. Routledge, : 71-97.
[84] Wolfrum N .2020 .Infectious laryngotracheitis: An update on current approaches for prevention of an old disease. J Anim Sci, 98(Supplement) : S27-S35.
[85] Wong LH,Tremethick DJ .2024 .Multifunctional histone variants in genome function. Nature Rev Genet, : 1-23.
[86] Wong W,Gauld J,Famulare M .2020 .From vaccine to pathogen: Modeling Sabin 2 vaccine virus reversion and evolutionary epidemiology. medRxiv 1-36., : .
[87] Wu M,Su Z,X Z .2022 .Biological characteristics of infectious laryngotracheitis viruses isolated in China. Virus, 14(6) : 1200.
[88] Yang Z,Murata S,Fujisawa S .2020 .Molecular detection and genetic characterization of infectious laryngotracheitis virus in poultry in Myanmar. BMC Vet Res, 16 : 1-10.
[89] Yegoraw AA,Assen AM,Gerber PF .2021 .Transmission of infectious laryngotracheitis virus vaccine and field strains: the role of degree of contact and transmission by whole blood, plasma and poultry dust. Vet Res, 52(1) : 91.
[90] Zeng Z,Wang Z,Wang X .2024 .Spray Vaccination with a Newcastle Disease Virus (NDV)-Vectored Infectious Laryngotracheitis (ILT) Vaccine Protects Commercial Chickens from ILT in the Presence of Maternally Derived Antibodies. Avian Pathol (accepted), : 1-11.
[91] Zhang W,Wang X,Gao Y,- Y .2022 .-epidemic of infectious bursal disease virus in China. Virus, 14(10) : 2253.
[92] Zhou Y,Li L,Yu Z .2022 .Dermatophagoides pteronyssinus allergen Der p 22: Cloning, expression, IgE binding in asthmatic children, and immunogenicity. Pediat Allergy Immunol, 33(8) : e13835.
[93] Zorman Rojs O,Dovč A,Krapež U .2021 .Detection of laryngotracheitis virus in poultry flocks with respiratory disorders in Slovenia. Virus, 13(4) : 707.
Citations
Citations are not available for this document.
0

Citations

0

Downloads

11

Views